|
MYST2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.041100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.020200E-04 |
| Normal-vs-Stage2 |
3.462000E-01 |
| Normal-vs-Stage3 |
4.06619999999691E-05 |
| Normal-vs-Stage4 |
2.374900E-04 |
| Stage1-vs-Stage2 |
3.643600E-02 |
| Stage1-vs-Stage3 |
1.308180E-01 |
| Stage1-vs-Stage4 |
2.734600E-01 |
| Stage2-vs-Stage3 |
3.820900E-03 |
| Stage2-vs-Stage4 |
9.221600E-03 |
| Stage3-vs-Stage4 |
9.482400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.230040E-04 |
| Normal-vs-AfricanAmerican |
4.190000E-01 |
| Normal-vs-Asian |
4.193400E-04 |
| Caucasian-vs-AfricanAmerican |
8.114200E-02 |
| Caucasian-vs-Asian |
6.537800E-01 |
| AfricanAmerican-vs-Asian |
1.015390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.771510E-04 |
| Normal-vs-Female |
6.168800E-04 |
| Male-vs-Female |
4.261000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.563200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.800900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.063850E-03 |
| Normal-vs-Age(81-100Yrs) |
2.058000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.330000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.317800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.208000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.264800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.078200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.130200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.789580E-04 |
| Classical-VS-Follicular |
4.461700E-02 |
| Classical-VS-Other |
3.447800E-01 |
| Classical-VS-Normal |
4.024400E-04 |
| Tall-VS-Follicular |
1.5365599999928E-05 |
| Tall-VS-Other |
4.959400E-01 |
| Tall-VS-Normal |
6.29149999875622E-08 |
| Follicular-VS-Other |
1.608960E-01 |
| Follicular-VS-Normal |
1.346190E-01 |
| Other-VS-Normal |
2.911900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.744400E-03 |
| Normal-vs-N1 |
2.38429999999124E-06 |
| N0-vs-N1 |
2.738200E-03 |
|
|
